Prediction of Visual Acuity after anti-VEGF Therapy in Diabetic Macular Edema by Machine Learning
Purpose. To predict visual acuity (VA) 1 month after anti-vascular endothelial growth factor (VEGF) therapy in patients with diabetic macular edema (DME) by using machine learning. Methods. This retrospective study included 281 eyes with DME receiving intravitreal anti-VEGF treatment from January 1,...
Saved in:
Main Authors: | Ying Zhang, Fabao Xu, Zhenzhe Lin, Jiawei Wang, Chao Huang, Min Wei, Weibin Zhai, Jianqiao Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2022/5779210 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prediction of OCT contours of short-term response to anti-VEGF treatment for diabetic macular edema using generative adversarial networks
by: Xueying Yang, et al.
Published: (2025-04-01) -
Switch to Aflibercept in Diabetic Macular Edema Patients Unresponsive to Previous Anti-VEGF Therapy
by: Filipe Mira, et al.
Published: (2017-01-01) -
Association between Visual Acuity and Retinal Layer Metrics in Diabetics with and without Macular Edema
by: LakshmiPriya Rangaraju, et al.
Published: (2018-01-01) -
Ellipsoid Zone Integrity and Visual Acuity Changes during Diabetic Macular Edema Therapy: A Longitudinal Study
by: Lucy J. Kessler, et al.
Published: (2021-01-01) -
Combination of Anti-VEGF and Laser Photocoagulation for Diabetic Macular Edema: A Review
by: Laura N. Distefano, et al.
Published: (2017-01-01)